Orphan Medicines in Wales

In this issue’s column, the All Wales Medicines Strategy Group reviews the impact of changes to the appraisal process for medicines for rare diseases in Wales. In September 2015 the All Wales Medicines Strategy Group (AWMSG) updated the policy for appraising medicines developed to treat rare diseases. Reviewing the impact of the changes shows that [...]